姜冬梅 , 康波 , 马容 , 何珲 . 烯醇化酶1的生物学功能[J]. 动物营养学报, 2014 , 26(1) : 69 -73 . DOI: 10.3969/j.issn.1006-267x.2014.01.010

[1] ZHU L A, FANG N Y, GAO P J, et al.Differential expression of α-enolase in the normal and pathological cardiac growth[J].Experimental and Molecular Pathology, 2009, 87(1):27-31.  

[2] WISTOW G J, LIETMAN T, WILLIAMS L A, et al.Tau-crystallin/alpha-enolase:one gene encodes both an enzyme and a lens structural protein[J].The Journal of Cell Biology, 1988, 107(6):2729-2736.  

[3] PANCHOLI V.Multifunctional α-enolase:its role in diseases[J].Cellular and Molecular Life Sciences, 2001, 58(7):902-920.  

[4] MILES L A, DAHLBERG C M, PLESCIA J, et al.Role of cell-surface lysines in plasminogen binding to cells:identification of alpha-enolase as a candidate plasminogen receptor[J].Biochemistry, 1991, 30(6):1682-1691.  

[5] ARZA B, FÉLEZ J, LÓPEZ-ALEMANY R, et al.Identification of an epitope of alpha-enolase (a candidate plasminogen receptor) by phage display[J].Thrombosis and Haemostasis, 1997, 78(3):1097-1103.

[6] LONGSTAFF C, MERTON R E, FABREGAS P, et al.Characterization of cell-associated plasminogen activation catalyzed by urokinase-type plasminogen activator, but independent of urokinase receptor (uPAR, CD87)[J].Blood, 1999, 93(11):3839-3846.

[7] REDLITZ A, FOWLER B J, PLOW E F, et al.The role of an enolase-related molecule in plasminogen binding to cells[J].European Journal of Biochemistry, 1995, 227(1/2):407-415.

[8] LPEZ-ALEMANY R, LONGSTAFF C, HAWLEY S, et al.Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against α-Enolase[J].American Journal of Hematology, 2003, 72(4):234-242.  

[9] OSSOWSKI L, AGUIRRE-GHISO J A.Urokinase receptor and integrin partnership:coordination of signaling for cell adhesion, migration and growth[J].Current Opinion in Cell Biology, 2000, 12(5):613-620.  

[10] DAS R, BURKE T, PLOW E F.Histone H2B as a functionally important plasminogen receptor on macrophages[J].Blood, 2007, 110(10):3763-3772.  

[11] VON HEIJNE G, LILJESTRM P, MIKUS P, et al.The efficiency of the uncleaved secretion signal in the plasminogen activator inhibitor type 2 protein can be enhanced by point mutations that increase its hydrophobicity[J].The Journal of Biological Chemistry, 1991, 266(23):15240-15243.

[12] BOTTALICO L A, KENDRICK N C, KELLER A, et al.Cholesteryl ester loading of mouse peritoneal macrophages is associated with changes in the expression or modification of specific cellular proteins, including increase in an alpha-enolase isoform[J].Arteriosclerosis, Thrombosis, and Vascular Biology, 1993, 13(2):264-275.  

[13] MERKULOVA T, DEHAUPAS M, NEVERS M C, et al.Differential modulation of α, β and γ enolase isoforms in regenerating mouse skeletal muscle[J].European Journal of Biochemistry, 2000, 267(12):3735-3743.  

[14] LPEZ-ALEMANY R, SUELVES M, MUOZ-CNOVES P.Plasmin generation dependent on alpha-enolase-type plasminogen receptor is required for myogenesis[J].Thrombosis and Haemostasis, 2003, 90(4):724-733.

[15] DAZ-RAMOS A, ROIG-BORRELLAS A, GARCA-MELERO A, et al.Requirement of plasminogen binding to its cell-surface receptor α-enolase for efficient regeneration of normal and dystrophic skeletal muscle[J].PLoS One, 2012, 7(12):e50477.

[16] BRYER S C, KOH T J.The urokinase-type plasminogen activator receptor is not required for skeletal muscle inflammation or regeneration[J].American Journal of Physiology:Regulatory, Integrative and Comparative Physiology, 2007, 293(3):R1152-R1158.

[17] HABIB S S, ABDELGADER A G, KURDI M I, et al.Tissue plasminogen activator and plasminogen activator inhibitor-1 levels in patients with acute myocardial infarction and unstable angina[J].The Journal of the Pakistan Medical Association, 2012, 62(7):681-685.

[18] LUCKING A J, GIBSON K R, PATERSON E E, et al.Endogenous tissue plasminogen activator enhances fibrinolysis and limits thrombus formation in a clinical model of thrombosis[J].Arteriosclerosis, Thrombosis, and Vascular Biology, 2013, 33(5):1105-1111.  

[19] UCKER D S, JAIN M R, PATTABIRAMAN G, et al.Externalized glycolytic enzymes are novel, conserved, and early biomarkers of apoptosis[J].Journal of Biological Chemistry, 2012, 287(13):10325-10343.  

[20] O'MULLANE M J, BAKER M S.Loss of cell viability dramatically elevates cell surface plasminogen binding and activation[J].Experimental Cell Research, 1998, 242(1):153-164.  

[21] CESARMAN G M, GUEVARA C A, HAJJAR K A.An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA).Ⅱ.Annexin Ⅱ-mediated enhancement of t-PA-dependent plasminogen activation[J].The Journal of Biological Chemistry, 1994, 269(33):21198-21203.

[22] YANG H B, ZHENG W J, ZHANG X, et al.Induction of endothelial cell apoptosis by anti-alpha-enolase antibody[J].Chinese Medical Sciences Journal, 2011, 26(3):152-157.  

[23] ZHANG Y, CAI J T, ZHANG Y.Proteomics reveals protein profile changes in cyclooxygenase-2 inhibitor-treated endometrial cancer cells[J].International Journal of Gynecological Cancer, 2009, 19(3):326-333.  

[24] FEO S, ARCURI D, PIDDINI E, et al.ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor:relationship with myc promoter-binding protein 1 (MBP-1)[J].FEBS Letters, 2000, 473(1):47-52.  

[25] SUBRAMANIAN A, MILLER D M.Structural analysis of alpha-enolase.Mapping the functional domains involved in down-regulation of the c-myc protooncogene[J].Journal of Biological Chemistry, 2000, 275(8):5958-5965.  

[26] LO PRESTI M, FERRO A, CONTINO F, et al.Myc promoter-binding protein-1 (MBP-1) is a novel potential prognostic marker in invasive ductal breast carcinoma[J].PLoS One, 2010, 5(9):e12961.

[27] EJESKÄR K, KRONA C, CARÉN H, et al.Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death[J].BMC Cancer, 2005, 5:161.

[28] CHANG G C, LIU K J, HSIEH C L, et al.Identification of α-enolase as an autoantigen in lung cancer:its overexpression is associated with clinical outcomes[J].Clinical Cancer Research, 2006, 12(19):5746-5754.  

[29] CAPELLO M, FERRI-BORGOGNO S, CAPPELLO P, et al.α-Enolase:a promising therapeutic and diagnostic tumor target[J].FEBS Journal, 2011, 278(7):1064-1074.  

[30] CHEN X L, ZHOU L, YANG J, et al.Hepatocellular carcinoma-associated protein markers investigated by MALDI-TOF MS[J].Molecular Medicine Reports, 2010, 3(4):589-596.

[31] YAN G R, XU S H, TAN Z L, et al.Proteomics characterization of gastrokine 1-induced growth inhibition of gastric cancer cells[J].Proteomics, 2011, 11(18):3657-3664.  

[32] TAKASHIMA M, KURAMITSU Y, YOKOYAMA Y, et al.Overexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma:association with tumor progression as determined by proteomic analysis[J].Proteomics, 2005, 5(6):1686-1692.  

[33] STIERUM R, GASPARI M, DOMMELS Y, et al.Proteome analysis reveals novel proteins associated with proliferation and differentiation of the colorectal cancer cell line Caco-2[J].Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics, 2003, 1650(1/2):73-91.